Award
NIH Reporter #3R01CA283501-03S1
MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication
Recipient
National Cancer Institute (NCI), part of NIH
Award Amount
$31,622.00
Ceiling
$31,622.00
Awarded
April 17, 2026
Identifier
3R01CA283501-03S1
Award for a clinical trial testing MedSupport, an intervention to improve medication adherence in pediatric cancer patients with ALL, using electronic monitoring and biomarkers.
Description
This project involves a clinical trial to test the effectiveness of MedSupport, a multilevel intervention aimed at improving medication adherence in pediatric cancer patients, specifically those with Acute Lymphocytic Leukemia (ALL). The study will utilize electronic medication monitoring and biomarkers to measure adherence, with a focus on implementation and dissemination of the intervention.